Epidemiología e impacto de la otitis media aguda en la Comunidad ValencianaEpidemiology and burden of acute otitis media in valencia (spain)
Bibliografía (40)
- et al.
Otolaryngologic approach to the diagnosis and management of otitis media
Otolaryngol Clin North Am
(1991) - et al.
Otitis media in a population of black American and white American infants, 0–2 years of age
Int J Pediatr Otorhi-nolaryngol
(1995) - et al.
The occurrence of acute otitis media in infants. A life-table analysis
Int J Pediatr Otorhinolaryngol
(1991) - et al.
Utilización de la alternancia de antipiréticos en el tratamiento de la fiebre en España
An Esp Pediatr
(2001) An evidence-based approach to treating otitis media
Pediatr Clin North Am
(1996)Otitis media in children
N Engl J Med
(1995)- et al.
acute otitis media
Pediatr Rev
(1996) Treatment of acute otitis media and its complica-tions
Otolaryngol Clin North Am
(1994)- et al.
acute otitis media caused by antibiotic-resistantStreptococcus pneumoniae in southern Israel: Implication for immunizing with conjugate vaccines
J Infect Dis
(2000) Clinical implications of antibiotic resistance for mana-gement of acute otitis media
Pediatr Infect Dis J
(1998)
Antibiotic-resistant Streptococcus pneumoniae in acute otitis media: Overview and update
Pediatr Infect Dis J
Epidemiology of otitis media in children
Ann Otol Rhinol Laryngol
Otitis media aguda durante el primer año de vida y su relación con factores de riesgo
An Esp Pediatr
Otitis media aguda en una consulta de pediatría
An Esp Pediatr
Otitis media en la Infancia. Estudio de 20.532 casos
An Esp Pediatr
Efficacy of a pneumococcal conjugate vaccine against acute otitis media
N Engl J Med
Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: Evidence from Northern California
Eur J Pediatr
Efficacy, safety and immunogenicity of heptavalent pneu-mococcal conjugate vaccine in children
Pediatr Infect Dis J
Assessing costs and cost effectiveness of pneumococcal disease and vac-cination within Kaiser Permanente
Vaccine
Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children
Jama
Cited by (24)
Intratemporal and intracranial complications of acute mastoiditis in children. Why do they occur? An analysis of risk factors
2022, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :There are not many studies related to Acute Otitis Media (AOM) incidence in Madrid and Spain. Some authors describe an incidence of 12 cases per 100,000 children aged less than 14 years, and 60% of 4 years old have had AOM, based on a retrospective cohort study among pediatricians [2]. According to data showing by Lorenzo-Monasta et al., Western Europe has a slightly higher incidence than Central and East Europe [11].
Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: Shifting pathogens in the post-pneumococcal conjugate vaccination era
2013, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :Otitis media (OM) affects around 80% of children by 3 years of age and is a major reason for physician visits and antibiotic use in this population [1,2]. In Spain, the annual incidence of AOM in children <5 years of age is estimated at 328 (95%CI 296–364) per 1000 person-years [3] and almost all children with AOM receive antibiotic treatment [4,5]. Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hi) were the most frequently identified AOM pathogens in the pre-pneumococcal conjugate vaccine (PCV) era in Spain and elsewhere [6–11].
Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)
2011, VaccineCitation Excerpt :These serotypes, however, cause a small number of cases of the disease in children in Valencia (Table 2). Recently, in the UK, it has been shown a decreased circulation of these two serotypes after the implementation of the 2 + 1 schedule [24]. A study from The Netherlands reported an ICER of about 53,000 €/QALY after using the PCV-13 [20].
Cost-effectiveness analysis of pneumococcal vaccination in Spain
2011, Gaceta SanitariaOtitis media across nine countries: Disease burden and management
2010, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :Among the diseases surveyed, OM was the most common childhood infectious disease treated by physicians in all the countries. This perceived high case load accords with various publications identifying that OM in children aged <5 years is one of the most common childhood diseases requiring visits to primary care physicians [1,2,23]. The physicians surveyed estimated that 54% of visits were for new cases, with 38% being associated with recurrent episodes of OM.
The health care burden and societal impact of acute otitis media in seven European countries: Results of an Internet survey
2010, VaccineCitation Excerpt :The latter were proper referral rates; however, the percentages in our survey take into account more severe or recurrent AOM cases, for which an ENT specialist had probably already been consulted. The high use of antibiotics found in the survey, from 60.8% to 87.1%, is comparable to what has been reported for the UK [35], Italy [36], and Spain [8,34] but is of some concern because antibiotics provide only marginal benefit and promote antibiotic resistance [9]. For example, a study in Italy [13] showed that delayed prescription of antibiotics as recommended in Italian guidelines resulted in a significant reduction in the number of children who received antibiotics; only 34.9% of those eligible for delayed treatment received antibiotics within 28 days, without an increase in complications.